Roth Capital Maintains Buy on Cingulate, Lowers Price Target to $11
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
Roth Capital analyst Boobalan Pachaiyappan maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $12 to $11.
Roth Capital analyst Boobalan Pachaiyappan maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $12 to $11.